Literature DB >> 18042652

Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity.

Helene Siilin1, Jonas Rastad, Osten Ljunggren, Ewa Lundgren.   

Abstract

CONTEXT: Primary hyperparathyroidism (PHPT) and associated morbidity are comprehensively assessed in elderly females; however, less is known of the disease in younger women.
OBJECTIVES: Our objectives were to estimate the prevalence of mild disturbances in calcium homeostasis, which could be analogous with early PHPT, in a premenopausal population, and determine the potential presence of associated morbidity.
DESIGN: Initial results from this longitudinal study are from 2002-2004.
SETTING: We conducted a population-based screening of serum (s)-calcium in conjunction with routine mammography. PARTICIPANTS: Participants included premenopausal women, 40-50 yr of age (n = 1900). Cases fulfilling previously evaluated biochemical criteria for PHPT (n=214) were matched to controls (n = 214). MAIN OUTCOME MEASUREMENTS: All participants underwent investigation, including screening of parameters of calcium homeostasis, dual x-ray absorptiometry, and body mass index assessment, and filled out extensive health and quality of life (SF-36) questionnaires. Participants were divided into four groups depending on the relation between s-calcium/intact PTH. Statistical comparisons between cases and controls as well as among the four groups were performed to evaluate morbidity.
RESULTS: The prevalence of assumed mild PHPT, i.e. inappropriate intact PTH value in relation to total s-calcium, was estimated to be 5.1% (n = 96). Women with mild disturbances in calcium homeostasis had statistically significant lower bone mineral density in the proximal femur and femoral neck, higher body mass index, and lower scores for vitality and general health in the analysis of SF-36.
CONCLUSIONS: Mild disturbances in calcium homeostasis in premenopausal women were more prevalent than previously thought and were associated with obesity, lower bone mineral density, and decreased quality of life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042652     DOI: 10.1210/jc.2007-0600

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism.

Authors:  D Han; S Trooskin; X Wang
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

2.  Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.

Authors:  Helene Siilin; Ewa Lundgren; Hans Mallmin; Dan Mellström; Claes Ohlsson; Magnus Karlsson; Eric Orwoll; Osten Ljunggren
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

3.  Body Size and the Risk of Primary Hyperparathyroidism in Women: A Cohort Study.

Authors:  Anand Vaidya; Gary C Curhan; Julie M Paik; Molin Wang; Eric N Taylor
Journal:  J Bone Miner Res       Date:  2017-06-12       Impact factor: 6.741

4.  "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".

Authors:  María Piedra; María T García-Unzueta; Ana Berja; Blanca Paule; Bernardo A Lavín; Carmen Valero; José A Riancho; José A Amado
Journal:  BMC Med Genet       Date:  2011-12-20       Impact factor: 2.103

5.  Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument.

Authors:  Eeva M Ryhänen; Ilkka Heiskanen; Harri Sintonen; Matti J Välimäki; Risto P Roine; Camilla Schalin-Jäntti
Journal:  Endocr Connect       Date:  2015-07-08       Impact factor: 3.335

6.  Diffuse parathyroid hormone expression in parathyroid tumors argues against important functional tumor subclones.

Authors:  Felix Haglund; C Christofer Juhlin; Nimrod B Kiss; Catharina Larsson; Inga-Lena Nilsson; Anders Höög
Journal:  Eur J Endocrinol       Date:  2016-02-10       Impact factor: 6.664

Review 7.  MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.

Authors:  Jens Bollerslev; Camilla Schalin-Jäntti; Lars Rejnmark; Heide Siggelkow; Hans Morreau; Rajesh Thakker; Antonio Sitges-Serra; Filomena Cetani; Claudio Marcocci
Journal:  Eur J Endocrinol       Date:  2019-06-01       Impact factor: 6.664

8.  The influence of calcium-phosphate metabolism abnormalities on the quality of life in patients with hemodynamically significant mitral regurgitation.

Authors:  Olga Mozenska; Jacek Bil; Agnieszka Segiet; Dariusz A Kosior
Journal:  BMC Cardiovasc Disord       Date:  2019-05-16       Impact factor: 2.298

9.  Development of a new tool for assessing health-related quality of life in patients with primary hyperparathyroidism.

Authors:  Susan M Webb; Manel Puig-Domingo; Carles Villabona; Manuel Muñoz-Torres; Jordi Farrerons; Xavier Badia
Journal:  Health Qual Life Outcomes       Date:  2013-06-18       Impact factor: 3.186

10.  Epidemiology of Primary Hyperparathyroidism and its Non-classical Manifestations in the City of Recife, Brazil.

Authors:  Cátia Eufrazino; Andreia Veras; Francisco Bandeira
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2013-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.